Pressure BioSciences
(OTC) PBIO
Pressure BioSciences Financials at a Glance
Market Cap
$20,500
Revenue (TTM)
$1.50M
Net Income (TTM)
$31.36M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
3.21 (High)
Dividend
$0.00
Beta (Volatility)
3.21 (High)
Price
$0.00
Volume
70,000
Open
$0.00
Price
$0.00
Volume
70,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.20
Dividend
$0.00
Beta (Volatility)
3.21 (High)
Price
$0.00
Volume
70,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.20
PBIO News
PBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pressure BioSciences
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
16
CEO
Richard T. Schumacher
Website
www.pressurebiosciences.comHeadquarters
Canton, MA 02375, US
PBIO Financials
Key Financial Metrics (TTM)
Gross Margin
40%
Operating Margin
-5%
Net Income Margin
-15%
Return on Equity
0%
Return on Capital
29%
Return on Assets
-28%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$20.50K
Shares Outstanding
40.97M
Volume
70.00K
Short Interest
0.00%
Avg. Volume
4.04K
Financials (TTM)
Gross Profit
$799.56K
Operating Income
$9.50M
EBITDA
$9.39M
Operating Cash Flow
$3.19M
Capital Expenditure
$7.50K
Free Cash Flow
$3.19M
Cash & ST Invst.
$81.28K
Total Debt
$22.89M
Pressure BioSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$421.79K
-17.6%
Gross Profit
$44.25K
-82.7%
Gross Margin
10.49%
N/A
Market Cap
$20.50K
N/A
Market Cap/Employee
$1.37K
N/A
Employees
15
N/A
Net Income
$7.12M
-2.8%
EBITDA
$3.49M
-249.6%
Quarterly Fundamentals
Net Cash
$29.18M
-50.6%
Accounts Receivable
$183.98K
-2.7%
Inventory
$541.93K
-2.1%
Long Term Debt
$519.32K
+112.8%
Short Term Debt
$28.67M
+49.6%
Return on Assets
-27.93%
N/A
Return on Invested Capital
29.22%
N/A
Free Cash Flow
$705.91K
+21.5%
Operating Cash Flow
$705.91K
+21.5%